Structure-affinity relationships of adenosine A2B receptor ligands

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Receptor Biology

Background:

• Adenosine receptors, particularly A(1), A(2A), and A(3), have well-characterized agonists and antagonists.
• Recent advancements have led to the identification of selective compounds for the adenosine A(2B) receptor subtype.

Purpose of the Study:

• To review structure-affinity relationships of adenosine A(2B) receptor antagonists and agonists.
• To provide an overview of published scientific and patent literature on A(2B) receptor ligands.

Main Methods:

• Literature review of scientific and patent data.
• Analysis of structure-affinity relationships for A(2B) receptor ligands.
• Comparison of selectivity and affinity data for identified compounds.

Main Results:

• The xanthine analog, compound 16, is the most selective antagonist (>370-fold) with high affinity (1 nM).
• Pyrrolopyrimidine analog OSIP339391 shows high affinity (0.41 nM) and 70-fold selectivity.
• Other promising antagonists include triazolo, aminothiazole, quinazoline, and pyrimidin-2-amine analogs.
• Selective high-affinity agonists have also been developed, including non-ribose ligands with EC(50) values as low as 9 nM.

Conclusions:

• Significant progress has been made in developing selective and high-affinity ligands for adenosine A(2B) receptors.
• The identified compounds offer potential therapeutic applications by targeting the A(2B) receptor subtype.
• Further research into structure-activity relationships will likely yield even more potent and selective A(2B) receptor modulators.